Article Figures & Data
Tables
Variables Group I (n=1371) Group II (n=1371) Age (years) 31.38±6.73 32.24±6.65 18-24 226 (16.5) 203 (14.8) 25-40 1000 (72.9) 1010 (73.7) 41-53 145 (10.6) 158 (11.5) Gravity 3.41±1.83 3.33±1.68 Parity 2.57±1.34 2±1.20 Abortus 0.64±0.98 0.63±0.94 Curetage 0.18±0.4 0.13±0.34 Education None 138 (10.1) 123 (9.0) Preschool 7 (0.5) 10 (0.7) Elementary school 790 (57.6) 613 (44.7) Middle school 171 (12.5) 303 (22.1) High school 205 (15.0) 229 (16.7) University 30 (2.2) 64 (4.7) Master’s degree 2 (0.1) 2 (0.1) Doctorate 28 (2.0) 27 (2.0) Values are presented as numbers and precentages (%) or mean ± standard deviation (SD).
Recommended methods Age (years) 18-24 25-40 41-53 None 1 (0.2) 3 (0.1) 0 (0.0) Condom 41 (9.6) 217 (10.8) 99 (32.7) IUD 352 (82.1) 1516 (75.4) 161 (53.1) Depo-Provera 9 (2.1) 63 (3.1) 2 (0.7) OCP 16 (3.7) 113 (5.6) 16 (5.3) MPA 8 (1.9) 34 (1.7) 13 (4.3) BTL 2 (0.5) 62 (3.1) 9 (3.0) LNG-RIA 0 (0.0) 2 (0.1) 3 (1.0) Values are presented as numbers and precentages (%). IUD: intrauterine device, OCP: oral contraceptive pill, MPA: medroxyprogesterone acetate, BTL: bilateral tubal ligation, LNG-RIA: levonorgestrel-releasing intrauterine system
- Table 3
- Differences in recommended and at admission methods of contraception by the groups.
Study outcomes Group I (n=1371) Group II (n=1371) P-values At admission contraceptive method None 155 (11.3) 30 (2.2) <0.001 Coitus interruptus 788 (57.5) 978 (71.3) <0.001 Condom 134 (9.8) 91 (6.6) <0.001 IUD 169 (12.3) 165 (12.0) 0.06 Depo-Provera 23 (1.7) 23 (1.7) 0.5 OCP 84 (6.1) 69 (5.0) <0.001 MPA 16 (1.2) 14 (1.0) 0.003 LNG-RIA 2 (0.1) 1 (0.1) <0.001 Recommended contraceptive method None 2 (0.1) 2 (0.1) 0.5 Condom 224 (16.3) 153 (9.7) <0.001 IUD 941 (68.0) 1088 (79.4) <0.001 Depo-Provera 41 (3.0) 33 (2.4) <0.001 OCP 71 (5.2) 74 (5.4) 0.013 MPA 25 (1.8) 30 (2.2) <0.001 BTL 65 (4.7) 8 (0.6) <0.001 LNG-RIA 2 (0.1) 3 (0.2) 0.06 Values are presented as numbers and precentages (%). IUD: intrauterine device, OCP: oral contraceptive pill, MPA: medroxyprogesterone acetate, BTL: bilateral tubal ligation, LNG-RIA: levonorgestrel-releasing intrauterine system